StockWatch
·
Commodity Chemicals
Board Meeting27 Oct 2026, 05:20 pm

Valiant Laboratories Board Meeting on Nov 2, 2026 for Financial Results

AI Summary

Valiant Laboratories Limited has announced that its Board of Directors will convene on November 2, 2026. The primary agenda item is to consider and approve the Standalone and Consolidated Audited Financial Results for the quarter and half-year ended September 30, 2026. Additionally, the company has informed about the closure of the Trading Window from September 29, 2026, until November 4, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Key Highlights

  • Board meeting scheduled for November 2, 2026.
  • To approve financial results for Q2 FY27 and H1 FY27.
  • Both standalone and consolidated audited results will be reviewed.
  • Trading window closed until November 4, 2026.
  • Compliance with SEBI Insider Trading Regulations.